Triton Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,935
Closed -$533K 118
2021
Q1
$533K Buy
+5,935
New +$589K 0.36% 52

Other funds holding ARKG

Triton Wealth Management's ARKG Position: Q2 2021 in Review

Triton Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 5,935 shares — an estimated $533K sold.

Triton Wealth Management first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $533K in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Triton Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Triton Wealth Management sold 5,935 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $533K.
  • Triton Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Triton Wealth Management's ARK Genomic Revolution ETF position peaked at $533K in Q1 2021.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Triton Wealth Management's 13F filing for Q2 2021, filed 13 Aug 2021.